Sangamo Therapeutics, Inc. (SGMOQ)

Sangamo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.59	20.95	41.92	45.2	100.44	178.87
Short-Term Investments	-	-	-	35.8	177.19	197.68
Cash & Short-Term Investments	27.59	20.95	41.92	81	277.63	376.55
Cash Growth	9.55%	-50.03%	-48.25%	-70.82%	-26.27%	-41.30%
Total Trade Receivables	6.36	10.51	4.6	4.07	4.47	6.36
Other Current Assets	3.16	4.37	5.18	9.26	18.22	15.86
Total Current Assets	37.11	35.83	51.69	94.33	300.33	398.77
Net Property, Plant & Equipment	13.22	14.11	34.76	52.87	125.53	124.7
Other Intangible Assets	-	-	-	-	50.73	53.76
Goodwill	-	-	-	-	37.55	39.7
Long-Term Investments	-	-	-	-	29.85	88.17
Other Long-Term Assets	9.63	9.81	15.19	18.13	18.52	16.82
Total Assets	59.97	59.75	101.64	165.32	562.51	721.92

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	19.31	14.44	15.49	15.26	22.42	9.76
Accrued Expenses	33.43	27.13	22.76	32.47	37.51	32.42
Unearned Revenue	0.4	0.9	7.56	-	51.78	85.71
Total Current Liabilities	53.13	42.47	45.81	47.73	111.71	127.89
Long-Term Leases	19.33	25.09	26.25	33.52	38.99	44.06
Other Long-Term Liabilities	6.45	6.45	6.81	1.19	116.85	174.64
Total Long-Term Liabilities	25.79	31.55	33.06	34.7	155.84	218.69
Total Liabilities	78.92	74.01	78.87	82.43	267.55	346.58

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	4.14	3.51	2.13	1.78	1.67	1.46
Additional Paid-in Capital	1,638	1,611	1,532	1,492	1,450	1,334
Accumulated Other Comprehensive Income	-2.51	-1.46	-7.53	-4.6	-8.4	-3.99
Retained Earnings	-1,658	-1,627	-1,504	-1,406	-1,149	-956.27
Total Common Shareholders' Equity	-18.96	-14.27	22.77	82.89	294.96	375.34
Shareholders' Equity	-18.96	-14.27	22.77	82.89	294.96	375.34
Total Liabilities & Equity	59.97	59.75	101.64	165.32	562.51	721.92

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	19.33	25.09	26.25	33.52	38.99	44.06
Net Cash (Debt)	8.25	-4.15	15.67	47.49	238.65	332.49
Net Cash Growth	2615.13%	-	-67.01%	-80.10%	-28.23%	-44.86%
Net Cash Per Share	0.03	-0.01	0.08	0.27	1.55	2.30
Book Value	-18.96	-14.27	22.77	82.89	294.96	375.34
Book Value Per Share	-0.06	-0.05	0.11	0.48	1.91	2.60
Tangible Book Value	-18.96	-14.27	22.77	82.89	206.68	281.88
Tangible Book Value Per Share	-0.06	-0.05	0.11	0.48	1.34	1.95

Data Source: Fiscal.ai Last updated: May 14, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 9, 2026

Data Sources Report a data error